Baker Brothers Advisors - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$709,000
-84.1%
55,294
-81.1%
0.00%
-84.6%
Q1 2022$4,450,000
-13.9%
291,8010.0%0.03%
+4.0%
Q4 2021$5,168,000
-15.7%
291,8010.0%0.02%
-7.4%
Q3 2021$6,134,000
+6.6%
291,8010.0%0.03%
+8.0%
Q2 2021$5,754,000
-32.2%
291,8010.0%0.02%
-32.4%
Q1 2021$8,483,000
+162.6%
291,801
+173.7%
0.04%
+208.3%
Q4 2020$3,230,000
+71.9%
106,616
-9.7%
0.01%
+50.0%
Q3 2020$1,879,000
-23.5%
118,100
-5.1%
0.01%
-27.3%
Q2 2020$2,456,000
-20.3%
124,400
-50.2%
0.01%
-42.1%
Q1 2020$3,083,000
-33.3%
250,0000.0%0.02%
-24.0%
Q4 2019$4,623,000
+33.5%
250,0000.0%0.02%
+4.2%
Q3 2019$3,463,000
-5.4%
250,0000.0%0.02%
-4.0%
Q2 2019$3,660,000250,0000.02%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$91,046,41030.31%
Euclidean Capital LLC 746,674$3,748,3033.51%
StepStone Group LP 1,573,357$7,898,2521.03%
EcoR1 Capital, LLC 6,435,518$32,306,3000.98%
Rubric Capital Management LP 877,161$4,403,3480.19%
Boxer Capital, LLC 500,000$2,510,0000.13%
Jasper Ridge Partners, L.P. 348,250$1,748,2150.10%
FOX RUN MANAGEMENT, L.L.C. 45,798$229,9060.09%
PDT Partners, LLC 104,383$524,0030.08%
GSA CAPITAL PARTNERS LLP 129,279$6490.08%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders